In humans, mutations in BRAF frequently occur in various tumour types, such as melanoma, thyroid carcinoma, and colorectal carcinoma, and it has been shown that the BRAF mutation can show inter- and intratumoral heterogeneity [1,14,15,16,17]. This evidence concerns the gene BRAF and melanoma.